Organic compounds -- part of the class 532-570 series inventions 11/08

20080293945 - (pentaphenyl)phenyl group containing compound, polymeric derivative thereof and method for forming the same: P

20080293947 - Method of preparation for imidazolepyridines: The present invention relates to an improved process for preparing imidazo[1,2-a]pyridine-3-acetamides and more particularly, 6-methyl-2-p-tolylH-imidazo[1,2-a]pyridine.... Agent: Mallinckrodt Inc.

20080293946 - Process for preparing zolpidem hemitartrate and tartrate polymorphs: A method for preparing a polymorph of a hemitartrate salt of a compound having the structure: comprising dissolving a free base form of the compound in a liquid medium comprising an alcohol and a tartrate derivative to form a solution comprising the compound, the alcohol, and the tartrate derivative; heating... Agent: Mallinckrodt Inc.

20080293948 - Process for the preparation of keto compounds: A process for the preparation of 4-[1-oxo-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethylbenzeneacetic acid, useful as an intermediate for the preparation of fexofenadine, is provided.... Agent: Griffin & Szipl, PC

20080287678 - Multiple chromophores based on rylene: P

20080287679 - Process for preparing clopidogrel: The present invention encompasses processes for the preparation of optically pure clopidogrel camphorsulfonic acid salt without the need to isolate or recover (±) clopidogrel.... Agent: Kenyon & Kenyon LLP

20080287680 - Solifenacin succinate-containing composition: The solifenacin succinate-containing composition of the present invention has a reduced content of especially its optical isomers in comparison with the known compositions containing an acid addition salt of solifenacin, so that it can be used for production of a therapeutic agent containing solifenacin succinate. In addition, the above-described solifenacin... Agent: Sughrue-265550

20080287681 - Substituted benzimidazoles and their use for inducing apoptosis: wherein R represents aryl or heteroaryl, X is a bond, a carbonyl group, a derivative of a carbonyl group, an ethylene group or an ethylenecarbonyl group, R1 is optionally substituted amino or hydroxy, and the substituents R2 to R6 have the meanings given in the specification, to methods of synthesis... Agent: Gibbons P.C.

20080287682 - Substituted benzimidazoles and methods of preparation: Methods for preparing new substituted benzimidazole compounds having formula (I) useful for treating kinase mediated disorders are provided wherein R1, R2, R3, R4, a, b, and c are defined herein... Agent: Novartis Vaccines And Diagnostics Inc.

20080281103 - Azaspiro derivatives: P

20080281104 - Membrane-anchoring fluorescent probe: A membrane anchoring-type fluorescent probe consisting of a compound comprising a phospholipid residue, a fluorescent probe compound residue, and a linker which binds the residues (e.g., the compound represented by the following formula).... Agent: Greenblum & Bernstein, P.L.C

20080281105 - Novel quinolinium salts and derivatives: The present invention relates generally to the synthesis of novel quinolinium salts and derivative compounds. Such salts and compounds are useful for inhibiting the growth of cancer cells.... Agent: Law Office Of David Spolter C/o G. Singer

20080275239 - Metallic compound and organic electroluminescence device comprising the same: The present invention relates to a light emitting transition metal compound represented by the Chemical Formula 1 and Chemical Formula 2 and an organic electroluminescence device including the same. In the above Chemical Formulae 1 and 2, M is Ir, Pt, Rh, Re, Os, or the like, m is 2... Agent: Cantor Colburn, LLP

20080275240 - New and efficient process for the preperation of cabergoline and its intermediates: This invention relates to a new and efficient process for the production of dopamine agonists such as Cabergoline and the intermediates thereof.... Agent: Ivor M. Hughes, Barrister & Solicitor, Patent & Trademark Agents

20080275241 - Polymorphic forms of dolasetron base and processes of preparing dolasetron base, its polymorphic forms and salt thereof: The present disclosure relates to a process for the preparation of endo-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one or Dolasetron base. It also discloses a process for the preparation of endo-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one mesylate or Dolasetron mesylate. Further, the present disclosure relates to a process for producing Form I of Dolasetron base, and to the novel crystalline polymorphs,... Agent: Pharmaceutical Patent Attorneys, LLC

20080275242 - 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinoline compound: The invention provides compounds which exert excellent fungicidal activities against various plant diseases and are useful as active ingredients of pesticides permitting the control of rice blast and so on even in low dosages. Compounds represented by the general formulae (1a) to (1d) or salts thereof: (1a) (1b) (1c) (or)... Agent: Frishauf, Holtz, Goodman & Chick, PC

20080275243 - Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts: The present invention relates to the novel compounds Methyl 2-[(3S)-[3-[(2E)(7-chloro quinolin-2-yl)ethenyl]phenyl]-3-halopropyl]benzoates (IV) wherein the halo is chloro, bromo, iodo, starting from the known compound Methyl 2-[(3S)-[3-[(2E)-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (1). Reaction of Methyl 2-[(3S)-[3-[(2E)-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-hydroxypropyl]benzoate (1) with thionyl chloride or with methane sulfonyl chloride—lithium bromide or with trimethyl chlorosilane—sodium iodide in presence or absence... Agent: Schweitzer Cornman Gross & Bondell LLP

20080275244 - Heterocycle-substituted pyridine derivative's salt or crystal thereof: There is provided a heterocycle-substituted pyridine derivative's salt or a crystal thereof. The present invention provides an acid addition salt of 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-yl amine or a crystal thereof as well as process for producing the same.... Agent: Birch Stewart Kolasch & Birch

20080275245 - Processes for the preparation of substituted sulfoxides: The present invention relates to a process for enantioselective synthesis of substituted pyridinylmethyl sulfinyl-benzimidazole of compound of Formula (I). The process includes enantioselective catalytic oxidation of a substituted pyridinylmethyl prochiral sulfide derivative of compound of Formula (II) with an oxidizing agent in the presence of a chiral transition metal complex... Agent: Ranbaxy Inc.

20080275246 - Process for halomethyl ethers of hydroxyiminomethyl quaternary pyridinium salts: A halide salt of a 1-(hydroxyiminomethyl-1-pyridino)-3-(halomethyl)-2-oxapropane is prepared by adding a pyridinealdoxime to a bis-halomethylether in such a manner that the bis-halomethylether is maintained in excess throughout the addition. This procedure produces the halide salt of a 1-(hydroxyiminomethyl-1-pyridino)-3-(halomethyl)-2-oxapropane in high yield and purity, which facilitates its use as an intermediate... Agent: Townsend And Townsend And Crew, LLP